Are there any endocrine conditions associated with membranous nephropathy?

Endocrine Conditions Associated with Membranous Nephropathy

Yes, thyroid disorders—particularly Graves' disease, thyrotoxicosis, and hypothyroidism—are recognized endocrine conditions associated with membranous nephropathy, though these associations are relatively uncommon.

Primary Thyroid Disease Associations

Graves' Disease and Hyperthyroidism

The strongest evidence links Graves' disease and thyrotoxicosis with diffuse goiter to membranous nephropathy 1. A recent phenome-wide association study (2026) demonstrated a statistically significant association between genetically predicted Graves' disease and elevated risk of membranous nephropathy 1. The proposed mechanism involves:

• Proliferation and differentiation of lymphocytes and leukocytes
• Leukocyte-cell adhesion alterations
• CD4+ αβ T cell differentiation
• Th1 and Th2 cell differentiation pathways 1

Clinical presentation: When Graves' disease-associated MN occurs, patients typically present with nephrotic syndrome concurrent with symptomatic hyperthyroidism 2. Kidney biopsy reveals secondary MN pattern with negative PLA2R immunostaining, which is the key distinguishing feature from primary MN 2.

Hypothyroidism

Profound hypothyroidism has been rarely reported in association with membranous nephropathy 3. While uncommon, providers should check thyroid function tests in patients presenting with unexplained nephrotic proteinuria 3.

Distinguishing Secondary from Primary MN

The guidelines emphasize that secondary causes must be excluded in all MN cases 4. Key diagnostic approach:

1. Check anti-PLA2R antibodies: Positive results indicate primary (autoimmune) MN in most cases
2. Perform immunohistochemistry on biopsy: Look for PLA2R antigen staining
3. If PLA2R-negative: Consider secondary causes including thyroid disease 4

Important caveat: A small subset of patients may have anti-PLA2R antibodies AND features of another disorder, making causality versus coincidence difficult to determine 4.

Other Endocrine-Related Considerations

While not strictly endocrine, the guidelines note that malignancy (which can include endocrine tumors) is a recognized secondary cause of MN 4. Age-appropriate cancer screening is recommended, with additional testing only if specific risk factors or symptoms are present 4.

Treatment Implications

When thyroid disease is identified as the secondary cause:

• Treat the underlying thyroid disorder first 2, 5
• For Graves' disease: Methimazole with prednisone initially; if proteinuria persists at nephrotic levels despite clinical improvement, radioactive iodine therapy can produce dramatic reduction in proteinuria 2
• Eradication of the etiologic factor may lead to remission or cure of MN 5
• Immunosuppression targeting MN itself should be reserved for cases where treating the thyroid disorder alone is insufficient

Clinical Pitfalls to Avoid

1. Don't assume PLA2R-positive = purely primary disease: Rare cases can have both autoantibodies and secondary causes 4
2. Don't skip thyroid testing: Check TSH, free T4, and thyroid antibodies in all new MN diagnoses, especially if PLA2R-negative
3. Don't rush to immunosuppression: In secondary MN, treating the underlying cause (thyroid disease) should be the priority 5
4. Don't overlook autoimmune thyroiditis: Hashimoto thyroiditis can cause glomerular involvement in 10-30% of cases, with MN manifesting in up to 20% of those with glomerular involvement 2